By Fineline Cube 
Beijing-based biotech InnoCare Pharma (HKG: 9969, SHA: 688428) announced a strategic partnership agreement with Westlake University, China’s first modern private research-oriented university aiming to become one of the world’s top research institutes. The collaboration will focus on innovative drug research and development, platform co-construction, talent cultivation, and achievement transformation.
Collaboration Details
InnoCare will leverage Westlake University’s scientific research advantages in the field of innovation to explore multiple innovative drug targets. The company’s capabilities in biopharmaceutical research and development, clinical trials, and industrialization will enhance the efficiency of translating Westlake University’s scientific research results into practical applications.
Financial Terms
According to the agreement, InnoCare will provide preliminary financial support for the joint innovative drug research and development project. Milestone payments based on project progress will total up to RMB 54 million (USD 7.5 million).-Fineline Info & Tech